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Text 7
The WNT signaling pathway regulates patterning and morphogenesis during embryonic 8 development and promotes tissue renewal and regeneration in adults 1, 2 . Some WNT responses in 9 vertebrates depend on a second signal provided by the R-spondin family of four secreted proteins 10 (RSPO1-4) that drive the renewal of stem cells in many tissues 3, 4 . RSPOs markedly amplify 11 target cell sensitivity to WNT ligands by neutralizing two transmembrane E3 ligases, ZNRF3 12 and RNF43, which reduce cell-surface levels of WNT receptors 5, 6 . Chromosomal translocations 13 that increase RSPO expression or that inactivate ZNRF3/RNF43 can drive human cancers 7 . 14 RSPOs contain tandem furin-like repeats (FU1 and FU2), a thrombospondin type I (TSP) 15 domain, and a basic region (BR). RSPOs simultaneously engage ZNRF3/RNF43 through their 16 FU1 domain and one of three leucine-rich repeat-containing G-protein coupled receptors (LGR4-17 6) through their FU2 domain [8] [9] [10] [11] [12] , triggering the clearance of ZNRF3/RNF43 and the consequent 18 rise in WNT receptor levels.
LGRs are selectively expressed in various tissue stem cells and are 19 considered the primary high-affinity receptors for RSPOs [13] [14] [15] . Using purified mutant and 20 chimeric RSPOs and cell lines lacking various receptors, we show that RSPO2 and RSPO3, but 21 not RSPO1 and RSPO4, can potentiate WNT/b-catenin signaling in the absence of all three 22
LGRs. The ZNRF3/RNF43-interacting FU1 domain was necessary for LGR-independent 23 signaling, while the LGR-interacting FU2 domain was dispensable. The FU1 domain of RSPO3 24 was also sufficient to confer LGR-independence when transplanted to RSPO1, demonstrating 25 that its interaction with ZNRF3/RNF43 dictates LGR-independent signaling. The enigmatic 26 TSP/BR domains of RSPOs and their interaction with heparan sulfate proteoglycans (HSPGs), 27 previously considered dispensable for WNT/b-catenin signaling 16, 17 , became essential in the 28 absence of LGRs. These results define two alternative modes of RSPO-mediated signaling that 29 7
RSPO1 to potentiate WNT signaling in LGR4/5/6 KO cells (Fig. 3b, d ). Conversely, replacing the 122 FU1 domain of RSPO3 with that of RSPO1 drastically reduced the signaling capacity of RSPO3 123 in LGR4/5/6 KO cells (Fig. 3b, d ). In important control experiments, all chimeric ligands showed 124 equivalent activity in WT cells, establishing ligand integrity (Fig. 3b, c) . Thus, a difference in the 125 interaction between ZNRF3/RNF43 and the FU1 domains of RSPO1 and RSPO3 is the crucial 126 determinant of LGR-independent signaling. Of note, the affinities of the FU1-FU2 fragment of 127 RSPO2 (25 nM) and RSPO3 (60 nM) for ZNRF3 have been reported to be much higher than 128 those of RSPO1 (6.8 µM) and RSPO4 (300 µM)
12 . Indeed, these affinities correlate with the 129 capacity of RSPO2 and RSPO3, but not RSPO1 or RSPO4, to promote LGR-independent 130 signaling ( Fig. 1b) . While the TSP/BR domains of RSPO3 were required for LGR-independent 131 signaling, they were not sufficient because replacement of the TSP/BR domains of RSPO1 with 132 those of RSPO3 did not confer the capacity to signal in LGR4/5/6 KO cells (Fig. 3e) . In fact, the 133 TSP/BR domains of RSPO1 and RSPO3 seemed interchangeable for signaling activity in both 134
WT and LGR4/5/6 KO cells (Fig. 3e) . 135
These results suggested that the WNT-potentiating activity of RSPO3 in the absence of 136 the LGRs depends on its interaction with ZNRF3/RNF43 through the FU1 domain and an 137 additional interaction with an alternative co-receptor through the TSP/BR domains. We 138 considered the previous observation that the TSP/BR domains of RSPOs can bind to heparin 21 . 139
Addition of heparin to the culture medium completely blocked signaling by RSPO3 in 140
LGR4/5/6 KO cells, but had only a partial inhibitory effect on WT cells, in which RSPO3 can also 141 signal through LGRs (Fig. 4a) . 142
The TSP/BR domains of RSPOs can mediate interactions with the two major families of 143 cell-surface heparan sulfate proteoglycans (HSPGs), the transmembrane syndecans and the 144 glycophosphatidylinositol (GPI)-linked glypicans 17 . In humans, both protein families are 145 encoded by multiple, partially redundant genes: four syndecan genes (SDC1-4) and six glypican 146 genes (GPC1-6) 22 , all of which are expressed in HAP1 cells (Extended Data (Fig. 4b) . In contrast, the loss of EXTL3 in WT cells only reduced signaling by 34%, 153 likely because RSPO3 can also signal through LGR receptors in WT cells. In an important 154 control, the loss of EXTL3 did not affect signaling induced by addition of WNT3A alone or by 155 inhibition of the b-catenin destruction complex kinase GSK3 in either WT or LGR4/5/6 KO cells 156 (Fig. 4c) . 157
To distinguish between syndecans and glypicans, we took advantage of the fact that only 158 glypicans are anchored to the cell surface by a GPI linkage. Disrupting PIGL, a gene required for 159 GPI-anchor biosynthesis, or disrupting both GPC4 and GPC6 (the two glypican genes identified 160 in our previous haploid genetic screens 18 ) in LGR4/5/6 KO cells did not impair LGR-independent 161 potentiation of WNT signaling by RSPO3 (Fig. 4d) . 162
These results suggest that the interaction of the TSP/BR domains of RSPO3 with cell 163 surface HSPGs, possibly syndecans, provides an alternative mechanism that neutralizes 164 ZNRF3/RNF43 in the absence of LGR receptors (Fig. 4e) . Cell-surface HSPGs are known to 165 mediate the efficient endocytosis of multiple cargoes 24 . Hence, we speculate that the 166 simultaneous interaction of RSPO3 with ZNRF3/RNF43 through its FU1 domain and cell9 surface HSPGs through its TSP/BR domains provides an LGR-independent route for the 168 endocytosis and clearance of ZNRF3/RNF43 from the cell surface (Fig. 4e) , and the consequent 169 rise in WNT receptor levels. 170
Our work shows that RSPOs can potentiate WNT signals in the absence of LGR 171 receptors, expression of which has been hitherto considered the hallmark of RSPO-responsive 172 cells. Future work will define the developmental, regenerative, and oncogenic contexts in which 173 this LGR-independent mode of signaling is used to amplify target cell responses to WNT 174 ligands. The mutant and chimeric RSPO ligands we described should allow the selective 175 modulation of these alternate modes of signaling to dissect their biological roles. 176 10
Methods 177
The following materials and methods relevant to this manuscript have been described 178 respectively. The PCR product and pHLsec-HA-Avi-1D4 vector were both digested with AgeI 230
and KpnI, and ligated to produce pHLsec-HA-RSPO3DTSP/BR-Avi-1D4. 231
All constructs were sequenced fully and will be deposited in Addgene. and n = sample size) from each well was used to represent the data. Dose-response curves were 255 fitted using the nonlinear regression (curve fit) analysis tool in GraphPad Prism 7 using the 256 CNBr-activated sepharose 4B was dissolved in 50 ml of 1 mM HCl and allowed to swell. The 303 resin was transferred to an Econo-Pac chromatography column (Biorad Cat. # 7321010) and 304 washed by gravity flow with 50 ml of 1 mM HCl, followed by 50 ml of 0.1 M NaHCO 3 , 0.5 M 305 NaCl, pH 8.5. 14 mg of Rho 1D4 antibody were dissolved in 0.1 M NaHCO 3 , 0.5 M NaCl, pH 306 8.5, and incubated with the resin overnight, rotating at 4°C. The resin was washed with 50 ml of 307 0.2 M glycine, pH 8.0, and incubated for 2 hrs in the same buffer, rotating at RT. The resin was 308 washed sequentially with 50 ml each of: 0.1 M NaHCO 3 , 0.5 M NaCl, pH 8.5; 0.1 M NaOAc, 309 0.5 M NaCl, pH 4.0; 0.1 M NaHCO 3 , 0.5 M NaCl, pH 8.5; PBS, 10 mM NaN 3 . The packed resin 310 16
was resuspended in an equal volume of PBS, 10 mM NaN 3 to make a ~50% slurry, aliquoted and 311 stored at 4°C. 312 300 µl of the ~50% slurry of Rho 1D4 resin was added to a 50 ml conical tube containing 313 the CM, and the suspension was incubated 10 hrs rocking at 4°C. Following binding and during 314 all subsequent washes, the resin was collected by centrifugation for 5 min at 400 x g in a 315
swinging bucket rotor. The beads were wash three times at RT with 25 ml PBS by resuspending 316 the beads in buffer and mixing by inverting for ~1 min. Following the third wash the resin was 317 transferred to a 1.5 ml Eppendorf tube and washed three times with 1.4 ml of PBS, 10% glycerol. 318
Following the last wash, the buffer was aspirated and the resin was resuspended in 150 µl 319 of PBS, 10% glycerol to obtain a ~50% slurry. Tagged RSPO protein was eluted by adding 3 µl 320
of a 25 mM stock of 1D4 peptide ((NH 3 )-T-E-T-S-Q-V-A-P-A-(COOH)) for a final 321
concentration of 250 µM. Elution was carried out by rotating the tube sideways overnight at 4°C. 322
Following centrifugation of the resin, the eluate was recovered and reserved on ice. The resin 323 was resuspended in 150 µl of PBS, 10% glycerol, and 250 µM 1D4 peptide was added. A second 324 round of elution was carried out for 1 hr at RT. Following centrifugation of the resin, the second 325 eluate was recovered and pooled with the first. The final eluate was centrifuged once again to 326 remove residual resin, and the supernatant was aliquoted, frozen in liquid nitrogen and stored at -327 Fig. 1b)  330 4.5 µl and 13.5 µl of the final eluates containing tagged RSPO proteins were diluted with 331 4x LDS sample buffer (Thermo Fisher Scientific Cat. # NP0007) supplemented with 50 mM 332 tris(2-carboxyethyl)phosphine (TCEP), heated for 10 min at 95°C, and loaded alongside 333 Precision Plus Protein molecular weight standards (Bio-Rad Cat. # 1610373) and bovine serum 334 albumin (BSA) standards (Thermo Fisher Scientific Cat. # 23209) for quantification. Proteins 335 were electrophoresed in NuPAGE 4-12% Bis-Tris gels (Thermo Fisher Scientific) using 1X 336
80°C. 328 329
Quantification of tagged RSPO proteins by PAGE (see Extended Data
NuPAGE MES SDS running buffer (Thermo Fisher Scientific Cat. # NP0002). 337
Gels were fixed in 50% methanol, 7% acetic acid for 30 min, rinsed for 1.5 hrs with 338 several changes of water, stained for 2 hrs with GelCode Blue Stain Reagent (based on colloidal 339 coomassie dye G-250, Thermo Fisher Scientific Cat. # 24590), de-stained in water overnight, 340 and imaged using the Li-Cor Odyssey imaging system. Acquisition parameters for coomassie 341 fluorescence (700 nm channel) were set so as to avoid saturated pixels, and bands with intensities 342 within the linear range of fluorescence for the BSA standards were quantified using manual 343 background subtraction. 1:10,000 in blocking solution, washed with TBST followed by TBS, and imaged using the Li-356
Cor Odyssey imaging system. 357
358
Preparation of figures and statistical analysis 359
Illustrations were prepared using PowerPoint (Microsoft) and Illustrator CS6 (Adobe). 360
Tables and supplementary files were prepared using Excel and Word (Microsoft). Bar graphs, 361 dose-response graphs and circle graphs were prepared using Prism 7 (GraphPad Software) and 362 statistical analysis was performed using the same software. For comparisons between two 363 datasets, significance was determined by unpaired t test; for comparisons between more than two 364 datasets, significance was determined by one-way ANOVA. Significance is indicated as **** (p 365 < 0.0001), ** (p < 0.01), * (p < 0.05) or ns (not significant). Pictures of gels and immunoblots 366 were only adjusted for contrast and brightness when necessary for clarity using Photoshop CS6 367 (Adobe), and were arranged in Illustrator CS6. 368
369
Data availability 370
All data generated or analyzed during this study are included in this published article (and 371 its supplementary information files). LGR4/5/6 KO WT HAP1-7TGP
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